In Idiopathic Pulmonary Fibrosis, 4 Comorbidity Clusters May Reflect Phenotypes
Researchers in Denmark assessed the real-world prevalence of multimorbidity among adults with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Diagnosing Usual Interstitial Pneumonia via Endobronchial Optical Coherence Tomography
A study compared the diagnostic accuracy of endobronchial OCT in interstitial lung disease to the clinical judgment of blinded, independent pathologists and pulmonologists.
Effect of Pirfenidone vs Nintedanib on Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Investigators assessed the effect of pirfenidone and nintedanib on the risk for acute exacerbation of idiopathic pulmonary fibrosis in patients undergoing treatment with these antifibrotic agents.
Switching Antifibrotic Agents May Improve Outcomes in Idiopathic Pulmonary Fibrosis
Because the 2 antifibrotics in use — pirfenidone and nintedanib — have differing mechanisms of action, when one is ineffective the other may provide benefit, thus improving survival.
Effects of Changing Diagnosis Guidelines for Fibrotic Hypersensitivity Pneumonitis
Investigators called for further research to evaluate the new diagnostic guideline of fHP in a real-world cohort of patients with chronic FILD.
Effects of Pirfenidone on Polypharmacy in Idiopathic Pulmonary Fibrosis
Among patients with idiopathic pulmonary fibrosis, the use of pirfenidone does not delay new prescription of concomitant antitussive drugs.
Neuromuscular Electrical Stimulation in IPF: Findings From a Feasibility Trial
A future definitive trial is not feasible to assess the acceptability of neuromuscular electrical stimulation of the quadriceps muscles in people with idiopathic pulmonary fibrosis.
Azithromycin Does Not Improve Cough in Idiopathic Pulmonary Fibrosis
Patients with idiopathic pulmonary fibrosis being treated with low dose azithromycin for cough did not see significant improvements compared with placebo.
Idiopathic Pulmonary Fibrosis Clinical Diagnostic Scoring System Validated
The Fairfax idiopathic pulmonary fibrosis (IPF) clinical score was an accurate tool for estimating probability of IPF in patients with interstitial lung disease.
Valganciclovir Plus Pirfenidone Appears Safe, Tolerable in Idiopathic Pulmonary Fibrosis
There were no limiting safety or tolerability signals identified with the addition of valganciclovir to pirfenidone therapy in patients with idiopathic pulmonary fibrosis.
- Loading...
Loading...
Next post in Restrictive Lung Disease
Loading... 
Loading...